In its Q3 2026 10-Q filing, Dolby Laboratories introduced a refined accounting treatment that treats commissioning services related to Dolby Atmos Cinema Processor installations as distinct performance obligations. This change adds transparency to revenue recognition and highlights the growing importance of service-related revenue streams alongside traditional intellectual property licensing. The company’s enduring moat is reinforced by its strong patent portfolio and brand presence, although risks from consumer spending fluctuations and royalty collection persist. Growth prospects are underpinned by rising adoption of immersive audio/video formats and expansion into new entertainment venues and emerging markets.